Figure 14

![Figure 14: Summary comparison of anti-aggregation efficacy metrics for curcumin versus RuCurcumin across all experimental assays, highlighting the therapeutic advantage of metal complexation.]()

> Source: Massimiliano Cuccioloni et al. "Enhancing the Amyloid-β Anti-Aggregation Properties of Curcumin via Arene-Ruthen." *International journal of molecular sciences*, 2022. PMID: [35955845](https://pubmed.ncbi.nlm.nih.gov/35955845/)

<figure>
  <img src="" alt="Summary comparison of anti-aggregation efficacy metrics for curcumin versus RuCurcumin across all experimental assays, highlighting the therapeutic advantage of metal complexation." />
  <figcaption>Figure 14. Summary comparison of anti-aggregation efficacy metrics for curcumin versus RuCurcumin across all experimental assays, highlighting the therapeutic advantage of metal complexation.<br>  Source: Massimiliano Cuccioloni et al. "Enhancing the Amyloid-β Anti-Aggregation Properties of Curcumin via Arene-Ruthen." <em>International journal of molecular sciences</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35955845/">35955845</a></figcaption>
</figure>